Michel Mikhail - Nov 15, 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Chief Regulatory Officer
Signature
/s/ Erika L. Eves for Michel Mikhail, by power of attorney
Stock symbol
NAVB
Transactions as of
Nov 15, 2021
Transactions value $
$75
Form type
4
Date filed
12/2/2021, 03:08 PM
Previous filing
Oct 5, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAVB Stock Option Award $75.00 +75K $0.00* 75K Nov 15, 2021 Common Stock 75K $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.